2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Stomach Ulcer
2
Stomach Neoplasms
2
Thoracic Diseases
1
Overweight
1
Obesity
1
Lung Neoplasms
1
Liver Neoplasms
1
Intestinal Polyps
1
Intestinal Neoplasms
1
Interventions
Exercise
6
Counseling
6
Nutrition Assessment
5
Methods
3
Diet Therapy
3
Caloric Restriction
3
Tirzepatide
2
Resistance Training
2
Naltrexone
2
Metformin
2
Megestrol Acetate
2
Exenatide
2
Educational Status
2
Early Intervention, Educational
2
Diet
2
Cognitive Behavioral Therapy
2
Bupropion
2
Blood Specimen Collection
2
sultamicillin
1
semaglutide
1
licogliflozin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Ursodeoxycholic Acid
1
Urine Specimen Collection
1
Trehalase
1
Tobacco Use Cessation Devices
1
Tablets
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Overweight
×
(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled